Get started

ImmunoGen, Inc.

No trades
See on Supercharts
Overview
News Ideas Financials Technicals Forecast

IMGN chart

Key stats

Market capitalization
7.807BUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.29USD
Net income
−222.929MUSD
Revenue
108.782MUSD
Shares float
259.434M
Beta
0.83

About ImmunoGen, Inc.

Sector
Health Technology
Industry
Biotechnology
CEO
Mark Joseph Enyedy
Website
immunogen.com
Headquarters
Waltham
Employees (FY)
277
Founded
1981
ISIN
US45253H1014
ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA.

Ideas

Immunogen (NASDAQ: IMGN) Surge on News of Takeover by AbbVieAbbVie (NYSE:ABBV) announced Thursday that it will acquire Immunogen (IMGN) and its flagship cancer therapy, Elahere, in a deal worth $31.26 per share. The transaction values ImmunoGen (NASDAQ:IMGN) at a total equity value of approximately $10.1 billion and is expected to close in the middle of 202
Long
by DEXWireNews
$IMGN - Short it (Early analysis, the stock still can rally up)IMGN - Received ELAHERE approval with conditions. The condition is that they have to prove their claims with a single arm pivot. ELAHERE - Approved on Nov 2022, market reacted negative. (Opened 6.27, closed 5.00) Since approval the stock slid down to $4.00 Drug is expected to increase the longevi
Short
by UDAY_C_Santhakumar
1
IMGN Biotech Post Earnings IMGN had great earnings the last days of April and has been trending up ever since. It is riding the upper Bollinger band consistently in this past wee. The volume spike after earnings has subsided but ongoing volume is at about 5X the moving average of early April and March. Increased volume s
Long
by AwesomeAvani
March Gainers (IMGN, account up 1%)1st gainer in March is IMGN . Holding period is 2 days (2/27/23-3/1/23). Account is up 1%. This month till today, my account is up 1% My trading method is mostly short term and is independent of market swings. Will keep updating on my trades.
by 1hour_trading
ImmunoGen Inc. (IMGN) double-top indicates a short opportunityI was scanning stocks for chart patterns and came across Immunogen Inc. (IMGN) with a double-top already formed. IMGN has been trading in a downward channel since February 2021 and shows no sign of stopping yet. The price has reached a major support level of about 4.97, with only one major breach
Short
by cdnbuzzard
IMGN - ImmunoGen, Inc.Setup - simple base breakout after a solid 70% move off the lows followed by 5 weeks of consolidation. Earnings during consolidation were below expectation. However, after a slight selloff, shares were gobbled back up and volatility was squeezed out right below the breakout level. Half size becau
Long
by apaqu
IMGN Long - Triple BottomThe price seems to have reached a bottom after failing to break through a support level and ultimately rising higher in a sign of reversal to a new uptrend. The pattern formed over 6 hours and 0 minutes, which is a rough guide for how long it might take to reach the target price of 4.52 - 4.56... le
Long
by froglegs42

See all ideas 

News Flow

Keep readingKeep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Financials

Performance
Revenue to profit conversion
Earnings
‪0‬

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
TradeStation
TradeStation
Featured
Stocks, Crypto, Futures
4.4Very Good
Learn more
Interactive Brokers
Interactive Brokers
Stocks, Futures, Bonds
4.4Very Good
Learn more

See all brokers